Mycosis Fungoides — SCE Dermatology MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: C — T2 (patches/plaques ≥10% BSA)
The TNMB staging system for mycosis fungoides/Sézary syndrome uses T staging based on skin involvement: T1 = patches/plaques covering <10% BSA (T1a patches only, T1b plaques ± patches); T2 = patches/plaques covering ≥10% BSA; T3 = one or more tumour nodules (≥1 cm); T4 = erythroderma (≥80% BSA). With 15% BSA of patches/plaques, this is T2. N staging assesses lymph node involvement, M staging visceral involvement, and B staging blood involvement (Sézary cells). Stage IA (T1N0M0B0) has excellent 10-year survival (>95%); stage IB-IIA (T2N0M0B0) has 10-year survival of approximately 70-80%.
Reference: BAD 2019 CTCL Guidelines; EORTC-ISCL TNMB